Soleno Therapeutics(SLNO) - 2025 Q2 - Quarterly Results

Form 8-K Current Report Item 2.02 Results of Operations and Financial Conditions Soleno Therapeutics, Inc. announced preliminary Q2 2025 results via a press release, furnished as Exhibit 99.1, not "filed" under Section 18 - The company issued a press release on July 10, 2025, announcing preliminary financial results and operating metrics for the three months ended June 30, 2025[4] - Information furnished under Item 2.02, including Exhibit 99.1, is not deemed "filed" for Section 18 of the Exchange Act, nor incorporated by reference unless explicitly stated[5] Item 9.01 Financial Statements and Exhibits This section lists the exhibits filed with the Form 8-K, including the press release and interactive data file Exhibits Filed | Exhibit No. | Description | | :--- | :--- | | 99.1 | Press Release issued by Soleno Therapeutics, Inc., dated July 10, 2025 | | 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) | Signatures The report was officially signed on July 10, 2025, by Anish Bhatnagar, Chief Executive Officer - The report was signed on July 10, 2025, by Anish Bhatnagar, Chief Executive Officer[11]